VEGFA and lymphoid leukemia: In summary, reduced chemokine and VEGF secretion by malignant cells correlated with the Ra roughness index of microarc CaP coating is an effective competitive advantage that may distinguish this material for endoprosthetics and osteosynthesis in patients suffering from lymphoid leukemia.